Expectedly, the co‐delivery of CSF1R inhibitor and MAPK inhibitor resulted in re‐polarizing M2‐type macrophages to an anti‐tumor M1 phenotype and more robust tumor suppression than single delivery in an aggressive 4T1 tumor model. This evidence concerns the gene CSF1R and neoplasm.